Scholar Rock: De-Risked Biotech, Playing The Approval Catalyst (Buy Rating) — Positive
SRRK Seeking Alpha — November 10, 2025Scholar Rock Holding Corporation (SRRK) is a clinical-stage biotech focused on targeted therapies for neuromuscular and fibrotic diseases, with Apitegromab as its lead asset. SRRK's Apitegromab achieved strong phase 3 results in spinal muscular atrophy, showing meaningful motor function gains and robust safety as an add-on therapy. The recent stock correction was due to manufacturing site issues, not clinical setbacks; approval is expected by 2026, presenting a speculative buy opportunity.
MP Materials (NYSE:MP) is 7% higher to trade at $62.75 this morning, after the rare earths stock landed an upgrade to "buy" from "hold," as well as a price target hike to $71 from $68 at Deutsche Bank.
Will Sterling's 125% Data Centre Growth Extend Into 2026? — Positive
STRL Zacks Investment Research — November 10, 2025STRL's surging 125% data center revenues and deep project pipeline signal strong momentum extending into 2026.
Should You Buy, Sell, or Hold NuScale Power Stock Post Q3 Earnings? — Neutral
SMR Zacks Investment Research — November 10, 2025SMR's Q3 loss widens sharply, but major Small Modular Reactor deals with TVA and RoPower highlight long-term clean energy potential.
Acadia Healthcare to Participate in UBS 2025 Global Healthcare Conference — Neutral
ACHC Business Wire — November 10, 2025FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the UBS Global Healthcare Conference, November 9 - 12, 2025, in Palm Beach Gardens, Florida. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 1:45 p.m. Central Time / 2:45 p.m. Eastern Time on Tuesday, November 11, 2025. The live webcast of the presen.
Shareholder Alert: The Ademi Firm investigates whether TreeHouse Foods Inc. is obtaining a Fair Price for its Public Shareholders — Neutral
THS PRNewsWire — November 10, 2025MILWAUKEE , Nov. 10, 2025 /PRNewswire/ -- The Ademi Firm is investigating TreeHouse Foods (NASDAQ: THS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Investindustrial. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
Obamacare Stock Stung by Potential Healthcare Disruption — Negative
OSCR Schaeffers Research — November 10, 2025Oscar Health Inc (NYSE:OSCR) is sitting out today's broad market rally , last seen down 15.9% to trade at $14.98.
Tesla's Cybertruck chief quits after more than eight years in latest high-profile exit — Positive
TSLA New York Post — November 10, 2025Siddhant Awasthi, head of the Cybertruck program, announced his departure from Elon Musk's automaker late Sunday.
ReNew Energy Global Plc (RNW) Q2 2026 Earnings Call Transcript — Neutral
RNW Seeking Alpha — November 10, 2025ReNew Energy Global Plc ( RNW ) Q2 2026 Earnings Call November 10, 2025 8:30 AM EST Company Participants Anunay Shahi - Head of Investor Relations Sumant Sinha - Founder, Chairman & CEO Kailash Vaswani - Chief Financial Officer Vaishali Sinha - Cofounder of ReNew & Chairperson of Sustainability Conference Call Participants Justin Clare - ROTH Capital Partners, LLC, Research Division Nikhil Nigania - Sanford C. Bernstein & Co., LLC.
ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call Transcript — Neutral
ADCT Seeking Alpha — November 10, 2025ADC Therapeutics SA ( ADCT ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Nicole Riley Ameet Mallik - CEO & Director Mohamed Zaki - Chief Medical Officer Jose Carmona - Chief Financial Officer Conference Call Participants Eric Schmidt - Cantor Fitzgerald & Co., Research Division Jenna Li - Jefferies LLC, Research Division Leonid Timashev - RBC Capital Markets, Research Division Sudan Loganathan - Stephens Inc., Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Q3 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Monday, November …
3 Reasons Apple Stock is a Great Buy at New Highs — Positive
AAPL 24/7 Wall Street — November 10, 2025Apple (NASDAQ:AAPL) stock has been a surprisingly good performer in the last few months, thanks in part to some decent quarterly earnings results and optimism about iPhone 17 going into the holidays and beyond.
Nebius to Report Q3 Earnings: How to Approach the Stock Now? — Positive
NBIS Zacks Investment Research — November 10, 2025NBIS' surging AI cloud demand and $17.4B Microsoft deal boost momentum, but high capex and competition cloud near-term outlook.
Amazon Still Plans To Replace 250k New Jobs With Robots — Positive
AMZN 24/7 Wall Street — November 10, 2025It struck me how confident Amazon seemed heading into the holidays. When I told Lee about their plan to hire 250,000 seasonal workers, he didn't hesitate.
LNTH FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit — Neutral
LNTH Business Wire — November 10, 2025NEW YORK--(BUSINESS WIRE)---- $LNTH #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
Avio's US rocket motor plant to supply Raytheon and Lockheed Martin — Positive
LMT RTX Reuters — November 10, 2025Raytheon and Lockheed Martin will be the major customers of Avio's planned solid rocket motor plant in the United States, the Italian rocket maker said on Monday.
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm — Neutral
DXCM GlobeNewsWire — November 10, 2025NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) for violations of the federal securities laws on behalf of investors who purchased or acquired DexCom securities between July 26, 2024 and September 17, 2025, inclusive (the “Class Period”).
Schwab to Buy Forge Global to Boost Private Markets Offering, Stock Up — Positive
SCHW Zacks Investment Research — November 10, 2025SCHW's $660M Forge Global buyout accelerates its private markets strategy amid rising investor demand for pre-IPO access, with shares up 1.7%.
Telos Corporation (TLS) Beats Q3 Earnings and Revenue Estimates — Positive
TLS Zacks Investment Research — November 10, 2025Telos Corporation (TLS) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.1 per share a year ago.
Viasat Stock Soars on Wall Street Upgrade. What the Analyst Likes. — Positive
VSAT Barrons — November 10, 2025Brent Penter, of Raymond James, has upgraded shares to Buy from Hold. His price target is $52.
Alphabet's Breakout Is Here - Robust Advertising/Cloud/AI Monetization Prospects — Positive
GOOG GOOGL Seeking Alpha — November 10, 2025The market finally rewards GOOG's well-diversified Big Tech offerings across advertising monetization (through search and YouTube), AI/ cloud computing, and robo-taxi, amongst others. GOOG continues to maintain its leading market share for search engine/ browser/ streaming end markets, which explains the double digits growth observed in the advertising segment. This is on top of its vertically integrated compute/ TPU/ AI capabilities, allowing Google Cloud to report profitable growth and growing multi-year backlog to $157.7B.